VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2

Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment

(2013) Daniela S. Ardelean et al.   ANGIOGENESIS

BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II

(2012) Jai-Hyun Kim et al.   ANGIOGENESIS

BMP9 and BMP10 are critical for postnatal retinal vascular remodeling

(2012) N. Ricard et al.   BLOOD

ALK1 Signaling Inhibits Angiogenesis by Cooperating with the Notch Pathway

(2012) Bruno Larrivée et al.   DEVELOPMENTAL CELL

Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output

(2012) Sophie Dupuis-Girod et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

PLGA-based nanoparticles: An overview of biomedical applications

(2012) Fabienne Danhier et al.   JOURNAL OF CONTROLLED RELEASE

Bevacizumab Attenuates VEGF-Induced Angiogenesis and Vascular Malformations in the Adult Mouse Brain

(2012) Espen J. Walker et al.   STROKE

Interaction between alk1 and blood flow in the development of arteriovenous malformations

(2011) P. Corti et al.   DEVELOPMENT

Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy

(2011) Tom T. Karnezis et al.   LARYNGOSCOPE

The physiological role of endoglin in the cardiovascular system

(2010) José M. López-Novoa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Arteriovenous malformation in the adult mouse brain resembling the human disease

(2010) Espen J. Walker et al.   ANNALS OF NEUROLOGY

Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment

(2010) Claire L. Shovlin   BLOOD REVIEWS

Efficacy of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis

(2010) Tom T. Karnezis et al.   LARYNGOSCOPE

An epistaxis severity score for hereditary hemorrhagic telangiectasia

(2010) Jeffrey B. Hoag et al.   LARYNGOSCOPE

A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines

(2009) Abhinav P. Acharya et al.   BIOMATERIALS

The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia

(2009) Jana Simonds et al.   LARYNGOSCOPE

Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis

(2009) Helia B. Schonthaler et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia

(2008) Tom G.W. Letteboer et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors

(2008) Brian S. Sorg et al.   JOURNAL OF BIOMEDICAL OPTICS